# OnCo record rejuv-access-survivorship-care-lmic (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-access-survivorship-care-lmic/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-access-survivorship-care-lmic" ;
  schema:name "After treatment in low and middle income countries: mostly nothing"@en ;
  schema:description "Most people in the world who survive cancer are offered no survivorship care at all. Specialist centres are rare, follow-up is limited, late effects are poorly documented, and the household pays. This is the largest gap in recovery care anywhere, and the one with the thinnest evidence base."@en ;
  schema:url <https://onco.cc/technologies/rejuv-access-survivorship-care-lmic/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Global_health> ;
  schema:citation <https://doi.org/10.3389/fpubh.2025.1601483>, <https://doi.org/10.1093/jnci/djz089> ;
  onco:status "emerging" ;
  onco:tag "rejuvenation", "survivorship", "measurement", "access", "global" ;
  onco:related <https://onco.cc/technologies/rejuv-access-what-it-costs-elsewhere/>, <https://onco.cc/technologies/rejuv-paed-chronic-disease-burden/> ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/global-oncology-access/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/rejuv-access-who-misses-out/>, <https://onco.cc/technologies/oncology-nursing/>, <https://onco.cc/technologies/rejuv-measure-functional-tests/> ;
  onco:terms <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/quality-of-life/>, <https://onco.cc/terms/financial-toxicity/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-rare-cancers/> .